日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Quemliclustat联合化疗(加或不加zimberelimab)治疗转移性胰腺腺癌:一项随机1期试验

Wainberg, Zev A; Manji, Gulam A; Bahary, Nathan; Ulahannan, Susanna V; Pant, Shubham; Spigel, David R; Uboha, Nataliya V; Oberstein, Paul E; Saeed, Anwaar; Beagle, Brandon; Kim, Ji Yun; Wang, Ning; Weeder, Ben; Shitole, Shravani; Mrouj, Karim; Scott, Jennifer R; Ensign, Lisa G; DiRenzo, Daniel M; Walters, Matthew J; Wu, Wilson; Kaplan, Angelo; Cho, Soonweng; Kabbarah, Omar; O'Reilly, Eileen M

The effect of IL-1β inhibitor canakinumab (Ilaris®) on IL-6 production in human skeletal muscle cells.

IL-1β抑制剂卡那单抗(Ilaris®)对人类骨骼肌细胞中IL-6产生的影响

Cordeiro-Santanach Anna, Morales Fiorella, Parquet Maria Del Carmen, Uaesoontrachoon Kitipong, Rowsell Joyce, Warford Jordan, Wu Wilson, Elustondo Pia, Hoffman Eric P, Nagaraju Kanneboyina

A vending machine for drug-like molecules - automated synthesis of virtual screening hits

用于销售类药分子的自动售货机——虚拟筛选结果的自动化合成

McMillan, Angus E; Wu, Wilson W X; Nichols, Paula L; Wanner, Benedikt M; Bode, Jeffrey W

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

一项随机III期临床试验,评估聚乙二醇化透明质酸酶α联合白蛋白紫杉醇加吉西他滨治疗透明质酸高表达转移性胰腺腺癌患者的疗效

Van Cutsem, Eric; Tempero, Margaret A; Sigal, Darren; Oh, Do-Youn; Fazio, Nicola; Macarulla, Teresa; Hitre, Erika; Hammel, Pascal; Hendifar, Andrew E; Bates, Susan E; Li, Chung-Pin; Hingorani, Sunil R; de la Fouchardiere, Christelle; Kasi, Anup; Heinemann, Volker; Maraveyas, Anthony; Bahary, Nathan; Layos, Laura; Sahai, Vaibhav; Zheng, Lei; Lacy, Jill; Park, Joon Oh; Portales, Fabienne; Oberstein, Paul; Wu, Wilson; Chondros, Dimitrios; Bullock, Andrea J

Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility

通过突变不相容性防止基于鸡蛋的H3N2季节性流感疫苗中发生抗原破坏性突变

Nicholas C Wu ,Huibin Lv ,Andrew J Thompson ,Douglas C Wu ,Wilson W S Ng ,Rameshwar U Kadam ,Chih-Wei Lin ,Corwin M Nycholat ,Ryan McBride ,Weiwen Liang ,James C Paulson ,Chris K P Mok ,Ian A Wilson

Post-Discharge Services for Different Diagnoses Than Index Hospitalization Predict Decreased 30-Day Readmissions Among Medicare Beneficiaries

出院后针对与首次住院诊断不同的疾病提供的服务可预测医疗保险受益人30天内再入院率的降低。

Tak, Hyo Jung; Chen, Li-Wu; Wilson, Fernando A; Goldsweig, Andrew M; Oleynikov, Dmitry; Hawking, Michael; Shih, Ya-Chen Tina

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer

一项II期生物标志物嵌入式研究,评估拉帕替尼联合卡培他滨作为一线疗法治疗晚期或转移性胃癌患者的疗效

LaBonte, Melissa J; Yang, Dongyun; Zhang, Wu; Wilson, Peter M; Nagarwala, Yasir M; Koch, Kevin M; Briner, Colleen; Kaneko, Tomomi; Rha, Sun-Young; Gladkov, Oleg; Urba, Susan G; Sakaeva, Dina; Pishvaian, Michael J; Hsieh, Ruey-Kuen; Lee, Wei-Ping; Lenz, Heinz-Josef

Warm ischemic injury is reflected in the release of injury markers during cold preservation of the human liver

人肝脏在冷保存过程中,损伤标志物的释放反映了温缺血性损伤。

Bruinsma, Bote G; Wu, Wilson; Ozer, Sinan; Farmer, Adam; Markmann, James F; Yeh, Heidi; Uygun, Korkut